Private Wealth Management Group’s Pacira BioSciences PCRX Stock Holding History

Private Wealth Management Group’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.06K	Hold	82	–	–	﹤0.01%	1179
2026 Q2	$2.08K	Hold	82	–	–	﹤0.01%	1154
2026 Q1	$1.85K	Hold	82	–	–	﹤0.01%	1104
2025 Q4	$2.12K	Hold	82	–	–	﹤0.01%	1063
2025 Q3	$2.11K	Hold	82	–	–	﹤0.01%	1099
2025 Q2	$1.96K	Hold	82	–	–	﹤0.01%	1087
2025 Q1	$2.04K	Hold	82	–	–	﹤0.01%	1046
2024 Q4	$1.54K	Buy	82 +59	+257%	+$1.04K	﹤0.01%	1186
2024 Q3	$347	Sell	23 -117	-84%	-$2K	﹤0.01%	1452
2024 Q2	$4.01K	Buy	140 +123	+724%	+$3.5K	﹤0.01%	791
2024 Q1	$497	Buy	+17	New	+$522	﹤0.01%	1447

Other funds holding PCRX

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return

Ellsworth Advisors Hudson, Ohio $620M AUM 38.17% 1-Year Est. Return

Inspire Investing Meridian, Idaho $2.37B AUM 29.82% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Private Wealth Management Group's PCRX Position: Q3 2026 in Review

Private Wealth Management Group held its Pacira BioSciences (PCRX) position steady in Q3 2026 at 82 shares worth $2.06K. The position accounts for ﹤0.01% of the portfolio, ranked #1179.

Private Wealth Management Group first reported a position in PCRX in Q1 2024 and has held it in 11 quarters since. The position peaked at $4.01K in Q2 2024. 37 funds tracked by Wall St. Rank hold PCRX as of Q3 2026.

Private Wealth Management Group held 82 shares of Pacira BioSciences worth $2.06K as of Q3 2026.
Private Wealth Management Group left its Pacira BioSciences share count unchanged in Q3 2026.
Pacira BioSciences made up ﹤0.01% of Private Wealth Management Group's portfolio in Q3 2026, its #1179 holding.
Private Wealth Management Group first reported a position in Pacira BioSciences in Q1 2024 and has held it in 11 quarters since.
Private Wealth Management Group's Pacira BioSciences position peaked at $4.01K in Q2 2024.
37 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2026.

Based on Private Wealth Management Group's 13F filing for Q3 2026, filed 19 Oct 2026.